Literature DB >> 11392615

Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice.

F P Bymaster1, P A Carter, L Zhang, J F Falcone, P W Stengel, M L Cohen, H E Shannon, J Gomeza, J Wess, C C Felder.   

Abstract

Determination of muscarinic agonist-induced parasympathomimetic effects in wild type and M2 and M4 muscarinic receptor knockout mice revealed that M2 receptors mediated tremor and hypothermia, but not salivation. The M4 receptors seem to play a modest role in salivation, but did not alter hypothermia and tremor. In the M2 knockout mice, agonist-induced bradycardia in isolated spontaneously beating atria was completely absent compared to their wild type litter mates, whereas agonist-induced bradycardia was similar in the M4 knockout and wild type mice. The potency of carbachol to stimulate contraction of isolated stomach fundus, urinary bladder and trachea was reduced by a factor of about 2 in the M2 knockout mice, but was unaltered in the M4 knockout mice. The binding of the muscarinic agonist, [3H]-oxotremorine-M, was reduced in cortical tissue from the M2 knockout mice and to a lesser extent from the M4 knockout mice, and was reduced over 90% in the brain stem of M2 knockout mice. The data demonstrate the usefulness of knockout mice in determining the physiological function of peripheral and central muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392615     DOI: 10.1016/s0024-3205(01)01041-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

2.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

3.  Muscarinic receptor-activated cationic channels in murine ileal myocytes.

Authors:  A V Dresviannikov; T B Bolton; A V Zholos
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

4.  Muscarinic receptor binding changes in postmortem Parkinson's disease.

Authors:  Caitlin McOmish; Geoff Pavey; Catriona McLean; Malcolm Horne; Brian Dean; Elizabeth Scarr
Journal:  J Neural Transm (Vienna)       Date:  2016-11-21       Impact factor: 3.575

5.  The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands.

Authors:  Jingjing Wang; Meng Wu; Zhangcheng Chen; Lijie Wu; Tian Wang; Dongmei Cao; Huan Wang; Shenhui Liu; Yueming Xu; Fei Li; Junlin Liu; Na Chen; Suwen Zhao; Jianjun Cheng; Sheng Wang; Tian Hua
Journal:  Nat Commun       Date:  2022-05-23       Impact factor: 17.694

6.  The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions.

Authors:  Alan S Braverman; Ronald J Tallarida; Michael R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  2008-03-13       Impact factor: 4.030

7.  Gastric body cholinergic contractile signal transduction in M2 and M3 receptor knockout mice.

Authors:  Michael R Ruggieri; Alan S Braverman
Journal:  J Recept Signal Transduct Res       Date:  2013-06-20       Impact factor: 2.092

8.  The deletion of M4 muscarinic receptors increases motor activity in females in the dark phase.

Authors:  Paulina Valuskova; Sandor T Forczek; Vladimir Farar; Jaromir Myslivecek
Journal:  Brain Behav       Date:  2018-07-06       Impact factor: 2.708

Review 9.  Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.

Authors:  Emma T van der Westhuizen; K H Christopher Choy; Celine Valant; Simon McKenzie-Nickson; Sophie J Bradley; Andrew B Tobin; Patrick M Sexton; Arthur Christopoulos
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

10.  In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.

Authors:  G Howell; L West; C Jenkins; B Lineberry; D Yokum; R Rockhold
Journal:  BMC Pharmacol       Date:  2005-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.